Measurement of superoxide release in the phagovacuoles of immune complex-stimulated human neutrophils.

[1]  S. Orkin,et al.  Chronic granulomatous disease. Molecular genetics. , 1988, Hematology/oncology clinics of North America.

[2]  J. Curnutte.  Classification of chronic granulomatous disease. , 1988, Hematology/oncology clinics of North America.

[3]  J. Bernardo,et al.  Time dependence of transmembrane potential changes and intracellular calcium flux in stimulated human monocytes , 1988, Journal of cellular physiology.

[4]  P. Newburger,et al.  Variant chronic granulomatous disease: modulation of the neutrophil defect by severe infection. , 1986, Blood.

[5]  J. Falloon,et al.  Neutrophil granules in health and disease. , 1986, The Journal of allergy and clinical immunology.

[6]  A. Tauber,et al.  Flavonoid impairment of neutrophil response. , 1986, Biochemical pharmacology.

[7]  J. Gallin,et al.  Diffusion of extracellular hydrogen peroxide into intracellular compartments of human neutrophils. Studies utilizing the inactivation of myeloperoxidase by hydrogen peroxide and azide. , 1985, The Journal of biological chemistry.

[8]  M. Seeds,et al.  Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. , 1983, Journal of immunology.

[9]  J. Whitin,et al.  Opsonized Zymosan-Stimulated Granulocytes-Activation and Activity of the Superoxide-Generating System and Membrane Potential Changes , 1981 .

[10]  R. Clark,et al.  Effects of the myeloperoxidase system on fluorescent probes of granulocyte membrane potential. , 1981, The Journal of biological chemistry.

[11]  H. Cohen,et al.  Correlation between membrane potential changes and superoxide production in human granulocytes stimulated by phorbol myristate acetate. Evidence for defective activation in chronic granulomatous disease. , 1980, The Journal of biological chemistry.

[12]  S. Brenner,et al.  Substoichiometric concentrations of cytochalasin D inhibit actin polymerization. Additional evidence for an F-actin treadmill. , 1979, The Journal of biological chemistry.

[13]  B. Babior,et al.  Oxygen-dependent microbial killing by phagocytes (second of two parts). , 1978, The New England journal of medicine.

[14]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[15]  D. Roos,et al.  Effect of cytochalasin B on the oxidative metabolism of human peripheral blood granulocytes. , 1976, Biochemical and biophysical research communications.

[16]  D. Roos,et al.  Production of hydrogen peroxide by phagocytizing human granulocytes. , 1975, The Journal of laboratory and clinical medicine.

[17]  T. Stossel.  Phagocytosis (third of three parts). , 1974, The New England journal of medicine.

[18]  T. Stossel,et al.  Phagocytosis (first of three parts). , 1974 .

[19]  B. Babior,et al.  Defective superoxide production by granulocytes from patients with chronic granulomatous disease. , 1974, The New England journal of medicine.

[20]  T. Stossel.  Phagocytosis. Pt. 2. , 1974 .

[21]  D. Bainton,et al.  SEQUENTIAL DEGRANULATION OF THE TWO TYPES OF POLYMORPHONUCLEAR LEUKOCYTE GRANULES DURING PHAGOCYTOSIS OF MICROORGANISMS , 1973, The Journal of cell biology.

[22]  S. Zigmond,et al.  Effects of cytochalasin B on polymorphonuclear leucocyte locomotion, phagocytosis and glycolysis. , 1972, Experimental cell research.

[23]  D. Nathan,et al.  Failure of nitro blue tetrazolium reduction in the phagocytic vacuoles of leukocytes in chronic granulomatous disease. , 1969, The Journal of clinical investigation.

[24]  A. Bøyum,et al.  Isolation of mononuclear cells and granulocytes from human blood. , 1968 .

[25]  R. Good,et al.  Fatal granulomatous disease of childhood. An inborn abnormality of phagocytic function. , 1966, Lancet.

[26]  A. Keston,et al.  SYNTHESIS OF DIACETYLDICHLOROFLUORESCIN: A STABLE REAGENT FOR FLUOROMETRIC ANALYSIS. , 1965, Analytical biochemistry.